With reports of Reglan-related tardive dyskinesia coming to the forefront of numerous lawsuits, it appears that the disorder can affect any number of users along possible demographic lines.

The medication was used beyond its guidelines, originally establishing a three-month period in which the drug could be used before complications could set in. As a result, Reglan accounts for the primary cause of tardive dyskinesia in the United States of America today. Following studies and lawsuits, the Food & Drug Administration put a warning on the drug, noting its connection to tardive dyskinesia.

Although studies have proven that elderly and female patients are more likely to develop the disorder after using the drug, new concerns have brought to light the presence of the drug-related disorder in infants, as well as less talked about cases in otherwise healthy adults. When an adult in their prime develops tardive dyskinesia, the disorder can move from small uncontrollable movements to worsened jerks and spasms. In some industries, the problems associated with this disorder can cause employees to lose their jobs, compromising their livelihoods.

If you or someone you love has been diagnosed with tardive dyskinesia after a treatment that included Reglan, you may be eligible for compensation. Contact the Reglan lawsuit attorneys of Williams Kherkher by calling 800-761-3187 today.